At a glance
- Originator Uriach
- Class Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 21 Dec 2001 Discontinued-Preclinical for Mycoses in Spain (PO)
- 23 Nov 1995 Investigation in Mycoses in Spain (PO)